[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Mirati Therapeutics stock is trading near its 52-week high. Social media is buzzing about potential acquisitions, driving positive price action.
Mirati Therapeutics, Inc. Common Stock (MRTX) is a publicly traded stock in the healthcare sector.
Mirati Therapeutics, Inc. Common Stock uses the ticker $MRTX for trading. Listed in the Stocks and category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The price is at its 1-year high, likely due to discussions about potential acquisitions and positive social sentiment.
1-Year High: $XXXXX on 2024-10-17
1-Year Low: $XXXXX on 2024-10-17
AltRank 24-Hour Time-Series Raw Data
Mirati Therapeutics, Inc. Common Stock (MRTX) is currently AltRank #1,958 based on combined combined social and market metrics
Daily Average: XXXXX
1 Week: XXX -XXXXX
1 Month: XXXXX +362
6 Months: XXXXX +81
1 Year: XXXXX +476
1-Year High: XXXXX on 2025-08-23
1-Year Low: XX on 2025-01-01
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -XX
1 Month: XX -X
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XXX on 2025-06-02
1-Year Low: XX on 2025-06-21
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXXXX +3,283%
1 Month: XXXXX +275%
6 Months: XXXXXX -XX%
1 Year: XXXXXXX -XX%
1-Year High: XXXXX on 2025-06-20
1-Year Low: X on 2025-03-16
Social Network | X |
---|---|
Engagements | XX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
1 Week: X no change
6 Months: XX -XX%
1 Year: XXX -XX%
1-Year High: XXX on 2024-10-22
1-Year Low: X on 2024-10-18
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning Mirati Therapeutics, Inc. Common Stock (MRTX) in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
1 Week: X no change
6 Months: XX -XX%
1 Year: XXX -XX%
1-Year High: XX on 2024-10-22
1-Year Low: X on 2024-10-18
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXXXXXXXXXXXXXXXXX%
Daily Average: XXXXXXX%
1 Week: XXXXXXX% -XXXXXXXXXXXXXXXXXXXXXXX%
1 Month: XXXXXX% -XXXXXXXXXXXXXXXXXXXXXX%
6 Months: XXXXXX% -XXXXXX%
1 Year: XXXXXX% -XXXXXX%
1-Year High: XXXXX% on 2024-10-22
1-Year Low: XXXXXX% on 2025-06-27
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2025-04-08
1-Year Low: XXXXXXX% on 2025-10-08
Top assets mentioned In the posts about Mirati Therapeutics, Inc. Common Stock in the last XX hours
Bristol-Myers Squibb Co (BMY) Cytokinetics Inc. (CYTK) Karuna Therapeutics, Inc. Common Stock (KRTX) Blueprint Medicines Corporation (BPMC) 4 (4)
Top topics mentioned In the posts about Mirati Therapeutics, Inc. Common Stock in the last XX hours
stocks healthcare, $bmy, $cytk, $krtx, $myok, $bpmc, $4
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$BMY patent cliff is a huge problem for the company. Expensive acquisitions $KRTX $MYOK (Camzyos sales accelerating but $CYTK might have the better drug) $MRTX $RYZB and $CELG in the past. BMS needs commercial drug assets imo. $MDGL $BBIO $AXSM $NBIX $TLX"
X Link @doepke_michel 2025-10-12T13:41Z 5573 followers, 8202 engagements
"I can make a habit of collecting pharma M&A options: ✌🏽 $BPMC: up to $X ($2 + $4) from $SNY $MRTX: $XX for 7Y (Jan 2031) from $BMY 💵💰"
X Link @TohJah7809 2025-08-02T12:15Z 2057 followers, XXX engagements